Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase 1 2Phase 4 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 176Neoplasm Metastasis 143Neoplasms 137Leukemia, Myeloid, Acute 131Colorectal Neoplasms 129Breast Neoplasms 117Ovarian Neoplasms 89Prostatic Neoplasms 88Melanoma 88Recurrence 85Multiple Myeloma 80Pancreatic Neoplasms 74Squamous Cell Carcinoma of Head and Neck 73Lung Neoplasms 72Glioblastoma 72Lymphoma, Non-Hodgkin 63Myelodysplastic Syndromes 61Triple Negative Breast Neoplasms 58Stomach Neoplasms 53Glioma 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Carcinoma, Renal Cell 48Small Cell Lung Carcinoma 47Endometrial Neoplasms 47Lymphoma, Large B-Cell, Diffuse 45Brain Neoplasms 43Carcinoma, Hepatocellular 41Lymphoma, B-Cell 40Advanced Solid Tumors 40Sarcoma 39

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Liver Diseases × 90 days × Clear all
NCT06600321 2026-06-01

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Alnylam Pharmaceuticals

Phase 1 Recruiting
158 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT07559474 2026-04-30

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Incyte Corporation

Phase 1 Not yet recruiting
16 enrolled
Lymphoid

Liver Diseases, Lymphoma, Follicular, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡